Philippe Lucas
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Study on ibogaine for methadone dependence treatment aims to establish safe detox protocol through first Phase-II trial. Weekly low-dose evaluations conducted to gather safety and efficacy data for future research.
Jose Carlos Bouso
Melissa Etheridge shares her journey of addiction struggles, healing, and founding the Etheridge Foundation to research plant medicine treatments for opioid use disorder. Her mission is to provide more effective
Melissa Etheridge
William Leonard Pickard, once a prominent figure in the drug world, served 20 years in prison for LSD production and now works as a senior advisor for various organizations. His
William Leonard Pickard, Vince Kadlubek
Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case
Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper
Psychedelic-assisted therapy's history, Bill W's admiration, and the need for peer support group understanding are discussed in relation to sobriety, recovery, and psychedelics.
Kevin Franciotti, Reilly Capps, Celeste Alvarez, Danielle Nova, Rick Barnett, Juliana Mulligan
Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.
Sandy Samberg
Harm reduction superheroes delve into risk mitigation and benefit maximization, exploring mindset, setting, and substances for safer drug experiences and systemic change.
Mitchell Gomez, Phoenix aka Mohawk Greene
Psilocybin research journey: investigating its use for treating tobacco addiction. Includes pilot study, comparative efficacy study, and upcoming multi-site clinical trial funded by NIDA.
International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.
Steve Rolles, Kasia Malinowska